UBS Group
WBMD

UBS Group’s WebMD Health Corp. WBMD Stock Holding History

UBS Group’s Portfolio WBMD Stock Details WBMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-124,548
Closed -$7.3M – 8290
2017
Q2 		$7.3M Buy
124,548
+14,689
+13% +$819K ﹤0.01% 1799
2017
Q1 		$5.79M Sell
109,859
-17,941
-14% -$916K ﹤0.01% 1966
2016
Q4 		$6.33M Sell
127,800
-78,822
-38% -$4.07M ﹤0.01% 1880
2016
Q3 		$10.3M Buy
206,622
+18,567
+10% +$1.02M 0.01% 1391
2016
Q2 		$10.9M Sell
188,055
-1,835
-1% -$115K 0.01% 1319
2016
Q1 		$11.9M Buy
189,890
+38,173
+25% +$2.05M 0.01% 1212
2015
Q4 		$7.33M Sell
151,717
-3,274
-2% -$146K ﹤0.01% 1656
2015
Q3 		$6.17M Sell
154,991
-14,183
-8% -$600K ﹤0.01% 1740
2015
Q2 		$7.49M Buy
169,174
+43,086
+34% +$1.97M 0.01% 1713
2015
Q1 		$5.53M Buy
126,088
+7,739
+7% +$321K ﹤0.01% 1993
2014
Q4 		$4.68M Buy
+118,349
New +$4.55M ﹤0.01% 2146

Other funds holding WBMD

AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

UBS Group's WBMD Position: Q3 2017 in Review

UBS Group sold out of WebMD Health Corp. (WBMD) in Q3 2017, closing a stake of 124,548 shares — an estimated $7.3M sold.

UBS Group first reported a position in WBMD in Q4 2014 and held it in 11 quarters. The position peaked at $11.9M in Q1 2016. 1 fund tracked by Wall St. Rank holds WBMD as of Q3 2017.

  • UBS Group reported no remaining WebMD Health Corp. position as of Q3 2017 after selling out during the quarter.
  • UBS Group sold 124,548 WebMD Health Corp. shares in Q3 2017, an estimated $7.3M.
  • UBS Group first reported a position in WebMD Health Corp. in Q4 2014 and held it in 11 quarters.
  • UBS Group's WebMD Health Corp. position peaked at $11.9M in Q1 2016.
  • 1 fund tracked by Wall St. Rank held WebMD Health Corp. as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.